Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. (Q46738356)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

title

Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

main subject

patient

0 references

liver transplantation

1 reference

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

author name string

M Berenguer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

A Palau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

V Aguilera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

J-M Rayón

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

F S Juan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

English

0 references

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

American Journal of Transplantation

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

679-687

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18294165 AND SRC:MED&resulttype=core&format=json

Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006).

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Treatment of hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X

Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2007.02126.X